Company Filing History:
Years Active: 1979-1991
Title: Klaus Lossnitzer: Innovator in Pharmaceutical Preparations
Introduction
Klaus Lossnitzer is a notable inventor based in Bad Kissingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive and cardio-protective medications. With a total of 2 patents, his work has the potential to impact the health and well-being of many individuals.
Latest Patents
Lossnitzer's latest patents include innovative pharmaceutical preparations that focus on treating hypertension and providing cardio-protective effects. One of his patents describes a pharmaceutical preparation that combines a pharmaceutically effective amount of a specific combination of active ingredients, including alpha-isopropyl-alpha-[(N-methyl-N-homoveratryl)-gamma-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, 2,4,7-triamino-6-phenyl-pteridine, and 6-chloro-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine-1,1-dioxide. This preparation is designed to be delivered in a single dosage form. Another patent focuses on a cardio-protective pharmaceutical composition that includes an inert carrier and a combination of triamterene and a calcium antagonist, such as verapamil.
Career Highlights
Klaus Lossnitzer is associated with Rohm Pharma GmbH, where he has been instrumental in advancing pharmaceutical research and development. His expertise in creating effective drug formulations has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Lossnitzer has collaborated with esteemed colleagues, including Karl-Friedrich Ober and Gerhard Giebenhain. These partnerships have fostered innovation and contributed to the successful development of his patented pharmaceutical compositions.
Conclusion
Klaus Lossnitzer's contributions to the field of pharmaceuticals, particularly in antihypertensive and cardio-protective preparations, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments that can improve patient outcomes.